According to Cognitive Market Research, the global Cell therapy Processing market size will be USD 4715.5 million in 2024. It will expand at a compound annual growth rate (CAGR) of 23.20% from 2024 to 2031.
North America held the major market share for more than 40% of the global revenue with a market size of USD 1886.20 million in 2024 and will grow at a compound annual growth rate (CAGR) of 21.4% from 2024 to 2031.
Europe accounted for a market share of over 30% of the global revenue with a market size of USD 1414.65 million.
Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 1084.57 million in 2024 and will grow at a compound annual growth rate (CAGR) of 25.2% from 2024 to 2031.
Latin America had a market share of more than 5% of the global revenue with a market size of USD 235.78 million in 2024 and will grow at a compound annual growth rate (CAGR) of 22.6% from 2024 to 2031.
Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 94.31 million in 2024 and will grow at a compound annual growth rate (CAGR) of 22.9% from 2024 to 2031.
The Neurological Disorders application segment is the fastest-growing in the Cell Therapy Processing Market due to the increasing focus on developing regenerative therapies for diseases like Alzheimer's, Parkinson's, and spinal cord injuries
